news roundup
EMD Serono, the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, launched a new clinical trial education website using TrialScope’s Engage and Disclose platforms.
A new report on the three-year performance of legislation requiring additional monitoring to certain medicines in the EU has not reached anticipated levels. The hope at the time was to promote a stream of real-world evidence about medicines authorized on the basis of limited clinical trials—where, for example, the number of patients is restricted and the available evidence has gaps or reservations.
|
|
advertisement
Transforming Regulatory Affairs: Sharing Industry Peer Perspectives
December 10, 2019 at 11am EST
Register Now
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Who has moved companies and what milestones are companies reporting this month? In this mid-month update, we hear from: KCR, AiCure, Advanced Clinical, CluePoints, Signant Health, TrialScope, Kayentis and more.
advertisement
Managing Signals in the Modern Pharmacovigilance Landscape
Wednesday, December 11, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now
|
Articles
This article describes ViiV Healthcare’s experience managing its compassionate use program for HIV patients, using a branded ideaPoint platform to optimize the request, evaluation, decision tracking and management of early access requests.
The Institute for Neurodegenerative Disorders (IND) serves as a prime example of how research institutions can better engage with community physicians to build referral networks. Founded in New Haven, Conn., in 2001, IND develops diagnostic tools and treatments for individuals with neurodegenerative disorders. Through several years of dedicated outreach to clinicians in the community, IND built a referral network of neurologists located across Connecticut.
|
|
|
advertisement
A Movement in Diabetes: Using Time-in-Range
Thursday, December 12, 2019 at 11am EST
Moderator: Amber Lowry, Senior Editor, Special Projects
Register Now
|
Blog Posts
In this article, Vimal Mehta, CEO, and Vince O’Neill, CMO, at BioXcel Therapeutics discuss how they are actively using AI to discover advanced therapies in CNS and oncology.
| |
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|